The design and synthesis of functional chemical derivatives of small organic molecules is usually a key step for the intricate production of a variety of bioconjugates. In this respect, the derivatization site at which the spacer arm is introduced in immunizing conjugates constitutes a highly critical parameter for the generation of high-affinity and selective antibodies. However, due to the usual complexity of the required synthetic procedures, the appropriate comparison of alternative tethering 10 positions has often been neglected. In the present study, meticulous strategies were followed to prepare synthetic derivatives of pyraclostrobin with the same linkers located at diverse rationally-chosen sites. Activity appraisal of antibodies and bioconjugates was carried out by bidimensional competitive direct and indirect immunoassays, and a superior performance of two of the three synthesized haptens was found. Finally, a detailed analysis of the conformations of the target molecule and the synthesized haptens in aqueous solution was done using computer assisted molecular modeling techniques. This study suggested 15 that the lower titers and affinities of one set of antibodies are most probably due to conformational effects of the spacer arm in the immunizing bioconjugate.
Introduction
The production of high-affinity and selective binders to small 20 organic molecules is a biotechnological research field of huge importance for such diverse disciplines as drug discovery, clinical diagnostics, food safety, and environmental monitoring. Antibodies are the paradigm of binding proteins due to their exquisite molecular recognition ability. Long ago, 25 Nobel-prize winner Karl Landsteiner was the first to discover that low molecular weight compounds become immunogenic only after association with a carrier protein, coining the term hapten for these substances. 1 Because small organic molecules usually lack ready-to-activate chemical groups for protein 30 conjugation, the generation of high-quality antibodies exhibiting the desired ligand-binding features strongly relies on the synthesis of suitable functional derivatives of the target analyte. Such synthetic derivatives should closely mimic the target ligand, maximizing the steric, hydrophobic, and 35 electronic similarity to the parent molecule. Most commonly, synthetic haptens incorporate a spacer arm to better display the molecule, thus facilitating its recognition by the receptor, despite the fact that direct coupling of the analyte to the carrier protein, when possible, has occasionally been 40 employed.
2 Although the physico-chemical characteristics of the analyte determine the optimum properties of the spacer arm for hapten conjugation, linear aliphatic bridges are known to cause negligible interferences over the production of antibodies if an optimum length of two to six carbon atoms is 45 maintained.
3 Nevertheless, a critical parameter for the production of antibodies is, most noteworthy, the derivatization site; that is, the position at which the spacer arm is attached to the molecule. The linker position will mold the final conformation of the conjugate and therefore, it will 50 settle the specific moieties that will be accessible for binding. Even if these general considerations are simple and qualitative, they have generally been extremely useful -in combination with rational and judicious chemical examination of the target molecule by qualified chemists -for the 55 synthesis of appropriate haptens and bioconjugates applied to the production of antibodies with the desired binding properties. Lately, molecular modeling techniques are being Strobilurins are a new class of synthetic biocides displaying outstanding properties and a new mode of action, so the introduction of the first strobilurin fungicides in 1996 meant a significant contribution to the fight against fungal diseases.
5
As part of an ongoing project aimed at obtaining high-affinity 70 antibodies and developing immunochemical methods to selectively detect the most relevant chemicals of the strobilurin family of pesticides, we chose pyraclostrobin (PY) as a model analyte to ascertain the influence of the spacer arm attachment site on the affinity of the derived antibodies. PY is 75 considered as a second generation strobilurin fungicide, and it is composed of a methoxycarbamate toxophore moiety, an aryl bridge, and a characteristic two-ring system ( Figure 1 ). In this article, we describe the synthesis of PY derivatives with the spacer arm located at different sites of the molecule. To 80 rigorously compare the suitability of these synthetic haptens for inducing the formation of high-affinity antibodies, a homogenous linker of comparable length and composition was used for coupling to the same carrier protein. Very few examples have been found in the literature in which the same 85 spacer arm was used to prepare several functionalized haptens through different derivatization sites in order to find the optimum orientation of the molecule. 6 Antisera, representing 5 the unbiased whole-response of the animal immune system, were chosen as the source of antibodies. The affinity and selectivity of the generated reagents were evaluated by competitive enzyme-linked immunosorbent assay (cELISA) using the conjugate-coated indirect and the antibody-coated 10 direct formats. Finally, our results were assessed with computer-generated molecular models of the target molecule and the synthesized haptens.
Results and discussion
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Chemistry
After a rational examination of the planar structure of PY (Figure 1 ), three key positions for the introduction of the spacer arm and analyte functionalization became readily apparent: the methoxycarbamate toxophore moiety, the arylic 20 bridge, and the chlorophenyl moiety. Accordingly, three PY analogues, namely, PYo5, PYa6, and PYs5 (Figure 1 ), were proposed as haptens for the production of high-affinity antibodies. All three structures maintained the complete hydrocarbon skeleton and the most characteristic functional 25 groups of the analyte, incorporating the hydrocarbon spacer arm at positions where minimum modifications of steric and electronic properties of the molecule were expected. Moreover, the length and composition of the spacer arms were nearly identical in all three haptens. The synthesis of haptens
30
PYa6 and PYs5 is herein reported for the first time, whereas the preparation of hapten PYo5 was previously described by our group in a study dealing with the influence of the spacer arm length on antibody production. 7 In hapten PYa6, the spacer arm is directly attached to the aryl ring that contains 35 the methoxycarbamate group through a single carbon-carbon bond, while in hapten PYs5 the hydrocarbon spacer chain is bonded to the other (opposite) aryl group through a sulphur bridge that replaced the chlorine atom of PY. A preliminary examination of the synthetic routes required for the 40 preparation of haptens PYa6 and PYs5 evidenced that rather laborious and multi-step schemes would be required to prepare these analogues. Initial attempts to introduce the spacer arm at the required positions directly on PY failed, so haptens had to be finally prepared by total synthesis starting 45 from ready available materials. We used an adaptation of the strategy previously reported for the preparation of PY 8 and related compounds, 9 which involved, for such cases, the alkylation of a 1-aryl-1H-pyrazol-3-ol with a methyl 2-(bromomethyl)-phenyl(methoxy)carbamate as the key 50 synthetic step for the elaboration of the characteristic PY framework.
The synthesis of hapten PYa6 (11) began with the iodination reaction of methyl methoxy(o-tolyl)carbamate (1) using iodine and silver sulphate in AcOH (Scheme 1). This reaction is 55 highly efficient and regioselective, affording exclusively the 4-iodo compound 2. Radical benzylic bromination of 2 with N-bromosuccinimide and azobisisobutyronitrile as the initiator under standard thermal conditions afforded a very low yield of the desired benzylic bromide, a result that contrasted with that 60 obtained in the bromination reaction of the non iodinated analogue (see below). However, an acceptable yield of benzyl bromide 3 was obtained when the free radical bromination of iodide 2 was undertaken with bromine under radiationinduced conditions at room temperature. Under these conditions, the reaction afforded a mixture of bromide 3 and unreacted starting material, together with minor amounts of the corresponding benzylic dibrominated derivative, which could not be separated by conventional chromatographic methods, so it was used as such in the following step. Thus, 70 the expected benzyl ether 7 was obtained in excellent yield from the reaction of this mixture with 1-(4-chlorophenyl)-1H-pyrazol-3-ol (6), readily prepared according to a literature procedure 10 by reaction of (4-chlorophenyl)hydrazine hydrochloride (4) with methyl 75 acrylate and oxidation of the resulting pyrazolidinone 5 with oxygen and catalytic CuCl in about 57% overall yield. Once the tricyclic ring system present in PY had been prepared, the synthesis of hapten PYa6 was completed via substitution of the iodine atom in 7 by the C6 hydrocarbon chain using 80 palladium catalyzed coupling methodology. Thus, Sonogashira cross-coupling of iodide 7 with alkyne tert-butyl ester 8 under standard conditions afforded the acetylenic compound 9, which was hydrogenated using Wilkinson's catalyst to give compound 10 in 90% overall yield for the two 85 steps. The synthesis of hapten PY6a was completed by hydrolysis of the tert-butyl ester group of 10, which took place in nearly quantitative yield by treatment with trifluoroacetic acid at 0 °C. gave the desired hapten PYs5 (20) with also an excellent yield.
Bioconjugates and antibodies
The hapten density of the immunogenic conjugates is a fundamental parameter that determines the titer and the 30 affinity of the generated antibodies. Hapten's carboxyl groups were activated for coupling to the ε-amine residues of the carrier proteins by standard procedures (see experimental part Six rabbits were immunized and blood samples were collected after the third immunization. Titers of the two BSA−PYa6 immunized animals were approximately 10 4 , whereas those of animals immunized with BSA−PYs5 and BSA−PYo5 were around 10 and 50 times higher, respectively.
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The titers did not improve after the fourth immunization, and consequently the animals were exsanguinated. Finally, two antisera were generated from each immunogen: antisera rPYa6#1 and #2 from immunogen BSA−PYa6, antisera rPYo5#1 and #2 from immunogen BSA−PYo5, and antisera 10 rPYs5#1 and #2 from immunogen BSA−PYs5.
The influence of the derivatization site of assay conjugates was evaluated for the two most common cELISA formats. Depending on the ELISA format, OVA−hapten conjugates were used as passive immobilized competitive reagent for 15 indirect assays whereas HRP−hapten conjugates were employed as enzyme tracer conjugates in direct assays. The binding properties of the generated polyclonal antibodies were initially evaluated as the IC 50 value of the inhibition curve that was retrieved in homologous competitive assays with PY as 20 free analyte (Table 2) . Standard curves were run using an array of concentrations of the antibody and the assay conjugate, so that a family of inhibition curves was generated; one curve for each combination of immunoreagents. This approach enabled a simultaneous, and therefore comparable, 25 determination of the IC 50 values under different experimental conditions, so information about antibody affinity was rapidly acquired without a previous titration assay. We found that, in the conjugate-coated indirect format, the antisera generally performed better (lower IC 50 values) when OVA−hapten 30 conjugates were employed at 0.1 µg/mL (Table 2) . Under optimum conditions for each combination of immunoreagents, antibodies derived from haptens PYo5 and PYs5 recognized PY with a similar affinity, with antiserum rPYs5#2 displaying the lowest IC 50 value (1.7 nM). On the contrary, antisera from 35 hapten PYa6 showed lower affinity. These divergent results were even more evident in the antibody-coated direct format, in which antibodies from hapten PYa6 clearly did not perform as advantageously as the antibodies derived from the two other haptens. Figure 2 shows the standard curve for the 40 optimized assay in the antibody-coated direct cELISA format resulting from the combination of antiserum rPYs5#2 with its homologous tracer HRP−PYs5. This assay afforded a theoretical limit of detection of 0.13 nM (50 ng/L).
The antibody apparent affinity that results from the 45 calculated IC 50 values may be influenced by the hapten conjugate that is used for solid phase coating in indirect assays or that is coupled to the enzyme in direct assays. Therefore, cELISAs were also undertaken with heterologous conjugates for each antiserum (Table 3) . Both, PYs5-type 50 antisera and PYo5-type antisera recognized the coating OVA−PYa6 conjugate. However, very modest improvements of the IC 50 values, if any, were observed with these heterologous assays as compared with the corresponding homologous combinations. On the contrary, PYa6-type 55 antisera did increase their apparent affinity to PY with heterologous OVA conjugates. As expected, the antibodycoated direct format was much more demanding about using heterologous haptens because no binding (or not enough binding) to the tracer conjugate was observed in most cases. 60 As a matter of fact, heterologous direct assays could only be developed with PYo5-derived antibodies in combination with the enzyme tracer HRP−PYa6 (Table 3) . Interestingly, antiserum rPYs5#2, displaying the highest affinity to PY in the homologous assays, was the only antibody unable to 65 recognize any heterologous haptens. Overall, the same conclusion was deduced from homologous and heterologous assays; that is, PYo5 and PYs5 haptens performed better as immunogens than hapten PYa6. For selectivity studies, competitive assays were run in the conjugate-coated indirect format with all of the antibodies at 75 the selected immunoreagent concentrations to give A max values between 1.0 and 1.5 and using PY and other analytes as competitors. Homologous conjugates were used in each case at 0.1 µg/mL, except for antiserum rPYa6#2, for which the OVA−PYa6 conjugate was used at 1.0 µg/mL. Remarkably, 80 no member of the strobilurin family other than PY was recognized by any of the antisera, disregarding the derivatization site of the immunogen. All of the strobilurin fungicides (azoxystrobin, picoxystrobin, kresoxim-methyl, trifloxystrobin, dimoxystrobin, fluoxastrobin, and 85 orysastrobin) were assayed up to 1 µM. The selectivity of the six antisera towards other fungicides like boscalid, famoxadone, fenamidone, or cyazofamid, which are [Pyraclostrobin] (nM) commonly formulated together with PY, was also investigated. Again, none of the antisera bound any of these compounds.
Computational analysis
PY is a medium-sized hapten with a very high degree of 5 conformational flexibility due to the large number of bonds that display free rotation (see Table 1SI in the ESI † ). As a previous step to study the molecular properties of the functionalized haptens, the lowest-energy conformers of PY in water were determined using computer assisted techniques. 10 This molecular search resulted in a large amount of conformers (see Figure 1SI ), which were processed and analyzed as described in the experimental part (see the section for determination of minimum-energy conformations). Figure 3 depicts the optimized geometry (PM3-H 2 O) of the 15 conformer that displayed the lowest energy value (refer to Figure 2SI for the geometries of the other minimum-energy conformers, their classification and selection). Interestingly, the PY molecule, like the natural strobilurin A and several of its analogues, 14 does not adopt an extended geometry in 20 solution. All minimum-energy conformations were characterized by two planar moieties -one plane was formed by the chlorophenyl and pyrazolyloxy moieties and the other plane was formed by the ortho-substituted benzene ring -with an angle between them varying from 100 to 120 degrees. A 25 more accurate representation of the true shape of PY is given by the electron density isosurface showed in the bottom of Figure 3 which also reflects the electrostatic potential at every point on the surface. Electronic distribution and geometry are objective criteria to assist hapten design and interpret 30 antibody behavior. Our experimental data clearly evidenced the advantage of haptens PYo5 and PYs5 over PYa6 with regard to the production of anti-PY antibodies (Tables 2 and  3 ). Sanvicens et al. 15 found that the best antibody for trichloroanisol was obtained with an immunizing hapten in which the spacer arm had been introduced by substitution of a C−Cl bond by a C−C linkage -which made the aromatic carbon atom much more positive. In contrast, the electronic distribution played a major role in the production of 50 antibodies against trichlorophenol. 6b To gain some insights into the molecular reasons underlying our results, the electronic properties of the three haptens were simulated by attaching the linkers to the appropriate position of the lowestenergy PY conformer. As depicted in Figure 4 , the 55 introduction of the spacer arm did not cause a significant alteration of the atomic charges, and very close electronic similarities between PY and the immunizing haptens were found. In hapten PYs5, the hydrocarbon spacer chain is tethered to the benzene ring through a sulfur bridge that 60 replaced the chlorine atom of PY. This substitution meant the highest observed modification of the electronic properties compared with the two other haptens (the partial charge at C1 in PYs5 changed by 37%). Nevertheless, this sort of replacement, which has been previously used for the design of 65 haptens for chlorine-containing analytes, 16 is less drastic than if a C−C bond had been formed. In addition, the antibody with the highest affinity to PY was derived from hapten PYs5, so electronic charges did not accounted by themselves for the observed differences among immunizing haptens. As a further step to understand the reason why hapten PYa6 was a poorer mimic of the PY molecule than haptens PYo5 and PYs5, the structure of the three synthesized haptens was modeled taking into account the flexibility of the spacer arm. In order to simplify this analysis, we assumed that in the 80 synthetic haptens the common PY framework can adopt a conformational disposition similar to that of PY itself. A preliminary estimation of the preferred orientation of the spacer arm in each hapten was done by calculating the conformer with the lowest energy in aqueous solution when 85 the two first C−C bonds of the spacer arm proximal to the backbone of the PY molecule were rotated independently 360º in 15º increments. From this study, we observed that the minimum energy conformers for haptens PYo5 and PYs5 showed a trend to display the linker away from the backbone 90 of the molecule. On the contrary, the lowest energy conformers of PYa6 showed that the linker has a certain tendency to bend over the molecule (Figure 5 ), a finding that provides a feasible explanation for the inferior performance of the PYa6 derivative as immunizing hapten. 
Conclusions
In order to obtain antibodies endowed with appropriate binding properties to small organic molecules, optimal functionalized derivatives of the target analyte must be 5 prepared. In the present study, multistep synthetic routes were carried out for a better understanding of the importance of the derivatization site. Molecular modeling studies indicated that, in the case of haptens PYo5 and PYs5, the spacer arm facilitated an adequate exposure of the skeleton of PY during 10 the immune response. On the contrary, the central position of the linker in the molecule of PYa6 could have caused steric hindrance that impaired the formation of a deep and tight binding pocket, typical of most antibody−hapten interactions. 17 Therefore, interactions between the linker arm 15 and the backbone of the molecule may occur not only if too long spacers are employed, as demonstrated in our previous paper, 5 but also because of an inappropriate tethering site. Acquisition of a larger body of knowledge and more profound studies are required in order to better understand the factors 20 influencing the formation and stabilization of the antibody−analyte complex. In practice, these antiseraparticularly those derived from haptens PYo5 and PYs5 -should become very useful reagents for the preparation of immunoaffinity columns intended for PY purification and provided by BASF AG (Limburgerhof, Germany). tert-Butyl hex-5-ynoate (8) and tert-butyl 5-bromopentanoate (15) were prepared from commercial hex-5-ynoic acid 18 and 5-bromopentanoic acid, respectively.
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Methyl 2-(bromomethyl)phenyl(methoxy) carbamate (18) was 40 prepared from tolylcarbamate 1. 20 All melting points were determined using a Kofler hot-stage apparatus or a Büchi melting point apparatus and are uncorrected. All NMR spectra were recorded in CDCl 3 or acetone-d 6 at rt on a Bruker AC-300 spectrometer (300. 13 
Determination of minimum-energy conformations
The initial generation of low-energy conformations and geometry optimizations of PY was made using the conformational space search program CONFLEX6 from Conflex Corp. (Tokyo, Japan) running on Windows XP. The 65 visualization and analysis interface BARISTA, a platform especially designed for conformational analyses, was used to create the initial parameters, and conformation search was carried out with MMFF94S (2006-11-24HGTEMP) parameters using the default configuration resources, except 70 for the upper limit value of conformational search that was set to cover an area of 10 kcal/mol within the most stable conformation (SEL = 10). 21 The GBSA continuum solvation method was also introduced to evaluate the solvation energy contribution to the steric energy. 22 The energy distribution of 75 conformers was established under steric energy analysis. Those conformations that were chemically significant (accounting for 99.8% of the computed population) were grouped based on dihedral angle values (refer to reoptimized, and the lowest-energy conformations thus obtained were selected as the minimum energy conformations of PY. Optimized geometries of haptens were also calculated using the semi-empirical method PM3 with COSMO water simulation using dihedral angle increments of 15º.
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Electrostatic potential energy surfaces were mapped over electron density isosurfaces using the same force field. The electron density probability value used for all calculations was 0.01 electrons Ǻ -3 .
Buffers and solutions
The following buffers were employed: PB, 100 mM sodium phosphate buffer, pH 7.4; PBS, 10 mM sodium phosphate 5 buffer, pH 7.4 with 140 mM NaCl; PBST, PBS containing 0.05% (v/v) Tween 20; CB, 50 mM carbonate−bicarbonate buffer, pH 9.6; and washing solution, 150 mM NaCl containing 0.05% Tween 20. PY and all other analytes were prepared as concentrated solutions in N,N-dimethylformamide 10 (DMF) and kept at -20 ºC in amber glass vials.
Hapten synthesis
The synthesis of hapten PYo5 was previously published. vacuum. The characterization data of the synthetic intermediates can be found in the ESI † . All solvents were purified by distillation and, if required, they were dried according to standard methods.
Synthesis of PYa6
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Methyl 4-iodo-2-methylphenyl(methoxy)carbamate (2). Ag 2 SO 4 (1.097 g, 3.51 mmol) and I 2 (0.893 g, 3.52 mmol) were successively added to a solution of methyl methoxy(o-tolyl)carbamate (1) (680 mg, 3.48 mmol) in glacial acetic acid (9 mL), and the reaction mixture was stirred for 20 30 h at rt in the dark. After this time, a yellowish precipitate of AgI was formed, which was removed by filtration. The filtrate and washes were diluted with water and extracted with CH 2 Cl 2 . The combined organic extracts were successively washed with aqueous NaHCO 3 , aqueous Na 2 S 2 O 7 , brine, and 35 dried. Evaporation of the solvent under vacuum gave 2 (1.093, 98%) as a viscous oil that had a purity greater than 95%, as judged by 1 H NMR analysis, and it was used in the next step without further purification. mixture was estimated to be 50−55% on the basis of the analysis of the mixture by NMR. (6) . A solution of sodium ethoxyde in ethanol, prepared by dissolving Na (882 mg, 38.3 mol) in anhydrous ethanol (27 mL), was added to a 55 suspension of 4-chlorophenylhydrazine hydrochloride (4) (3.00 g, 16.75 mmol) in dry toluene (27 mL) stirred under nitrogen at 40 ºC. After stirring at the same temperature for 10 min, methyl acrylate (7.21 g, 7.54 mL, 83.75 mmol) was added drop wise during 20 min and the resulting mixture was 60 stirred for 1.5 h. The reaction mixture was concentrated in a rotary evaporator to remove most of the ethanol, then diluted with water (300 mL) and extracted with benzene. The benzene extracts were extracted with 5% sodium hydroxide and the combined aqueous basic phases were acidified with acetic 65 acid to pH 6 and extracted with benzene. The organic layer was washed, dried, and concentrated to give nearly pure 1-(4-chlorophenyl)pyrazolidin-3-one (5) (2.35 g, 71%) as an amorphous solid.
Methyl 2-(bromomethyl)-4-iodophenyl(methoxy)
1-(4-Chlorophenyl)-1H-pyrazol-3-ol
The above solid (1.265 g, 6.43 mmol) and CuCl (68 mg, 70 0.32 mmol) were dissolved in DMF (13 mL) and O 2 was bubbled through the mixture during 3 h at rt. The reaction mixture was diluted with H 2 O (100 mL) and then stirred for 1 h. The formed precipitate was filtered off, washed with water, and dried to afford a brownish solid that was crystallized from 75 benzene to give 6 (993 mg, 80%) as a slightly colored solid; mp 190−192 ºC (from benzene), at 174−176 ºC flake-like crystals were transformed into needle like crystals (lit., 10 mp 181−182 ºC). (9) . Dry DMF (1.5 mL) and triethylamine (1.2 mL) 95 were added to a mixture of aryl iodide 7 (241.5 mg, 0.468 mmol), tert-butyl hex-5-ynoate (8) (117.9 mg, 0.702 mmol), Cl 2 Pd(PPh 3 ) 2 (9.3 mg, 1.3 10 -2 mmol), and CuI (3.6 mg, 1.9 10 -2 mmol) under nitrogen. The mixture was degassed through several freeze−thaw cycles, stirred at rt for 30 min and then at 100 60 ºC for 4 h. The resulting brownish reaction mixture was cooled down, filtered through cotton and most of the triethylamine was removed under vacuum. The residue was diluted with ethyl acetate and washed, dried, and concentrated. Purification by silica gel chromatography, using hexane−ethyl 105 acetate 9:1 as eluent, afforded compound 9 (255 mg, 98%) as an oil. 6-(3-((1-(4-chlorophenyl)-1H-pyrazol-3-yloxy) methyl)-4-(methoxy(methoxycarbonyl)amino)phenyl) hexanoate (10) . A solution of alkyne 9 (243 mg, 0.439 mmol) 110 and Wilkinson's catalyst (12.2 mg, 0.013 mmol, 3%) in tetrahydrofurane (3 mL) was evacuated and purged under an atmosphere of hydrogen gas. Then, the hydrogen pressure was regulated to 4 atmospheres and the reaction mixture was stirred at rt for 16 h, the solvent was removed under vacuum, 115 and the residue was purified by chromatography, using hexane−ethyl acetate 9:1 as eluent, to furnish compound 10 (220 mg, 92%). 3-((1-(4-Chlorophenyl)-1H-pyrazol-3-yloxy) 
tert-Butyl 6-(3-((1-(4-chlorophenyl)-1H-pyrazol-3-yloxy) methyl)-4-(methoxy(methoxycarbonyl)amino)phenyl)hex-5 -ynoate
tert-Butyl
6-(
Protein conjugate preparation
All of the synthesized haptens contained a free carboxylic 115 group for protein conjugation. The hapten-to-protein MR of each bioconjugate was calculated by MALDI-TOF-MS and by differential absorbance measurements. For MALDI-TOF-MS analysis, a fraction of each conjugate solution was extensively dialyzed against pure water at 4 ºC and lyophilized. Samples 120 were resuspended in acetonitrile−water 7:3 (v/v) containing 0.1% trifluoroacetic acid, and they were charged into the plate in between two layers of sinapinic acid.
Immunizing conjugates. BSA conjugates were prepared by the active ester procedure. Briefly, 20 µmol of hapten in DMF 125 was mixed with 20 µmol of N-hydroxysuccinimide and 20 µmol of N,N-dicyclohexylcarbodiimide also in DMF. Additional DMF was added to bring the final concentration of all reagents to 50 mM. Hapten activation was left to occur overnight at rt in amber vials. The day after, the reaction was centrifuged and the supernatant was collected. Next, 200 µL of activated hapten solution was added drop wise to 1.0 mL of a 15.0 mg/mL BSA solution in CB. The coupling reaction was allowed to happen during 4 h at rt with moderate stirring. The 5 initial hapten-to-protein MR in the reaction mixture was approximately 44:1. Finally, the conjugate was separated from uncoupled hapten by gel filtration on Sephadex G-25, using PB as eluent. The purified bioconjugate was diluted to 1.0 mg/mL with PB and stored at -20 ºC. For differential 10 absorbance measurements, the absorbance values of the conjugate at 280 and 260 nm were considered.
Coating conjugates. In this case, the coupling reaction of the hapten to the carrier protein was accomplished by the mixed anhydride procedure. Basically, 18 µmol of hapten was 15 dissolved in 180 µL of DMF and mixed with 18 µmol of tributylamine and 18 µmol of isobutyl chloroformate also in DMF. The concentration of all reagents was brought to 90 mM with DMF and the hapten was left to be activated during 1 h at rt. Next, 100 µL of activated hapten solution was added 20 drop wise to 2.0 mL of a 15.0 mg/mL OVA solution in CB. The coupling reaction was carried out during 2.5 h at rt with moderate stirring. The initial hapten-to-protein MR in the reaction mixture was approximately 13:1. Conjugates were processed and stored as described above.
25
Tracer conjugates. The mixed anhydride method was also used to prepare the corresponding enzyme conjugates. First, haptens were activated as described above and a 1/10 dilution in DMF was prepared after the incubation step. Next, 100 µL of this dilution was added drop wise to a 1.0 mL solution of 30 HRP at 2.2 mg/mL in CB. The coupling reaction was incubated for 4 h at rt with moderate stirring. The initial hapten-to-protein MR in the reaction mixture was approximately 18:1. The tracer was separated from uncoupled hapten by gel filtration on Sephadex G-25. For differential 35 absorbance measurements, the absorbance values of the conjugate at 400 and 280 nm were considered in this case. The purified tracer was brought to 1.0 mg/mL with PB and diluted 1:1 (v/v) with PBS containing 1% (w/v) BSA and 0.01% (w/v) thimerosal. The conjugate was stored at -20 ºC in amber glass 40 vials for long-term preservation and a working aliquot was kept at 4 ºC.
Antiserum production
Animal manipulation was performed in compliance with the laws and guidelines of the Spanish Ministry of Science and immunized by subcutaneous injection with 0.3 mg of conjugate BSA-PYo5, BSA-PYa6, or BSA-PYs5 following described procedures. 23 For further details see the ESI † .
Competitive immunoassays
All antisera were evaluated in the two classical cELISA 55 formats using both homologous and heterologous conjugates. Eight-channel electronic pipettes were employed for rapid and precise liquid dispensing. Microplates were washed four times with washing solution using a 96-channel ELx405 washer from BioTek Instruments (Winooski, VT). After the assay, the 60 absorbance was read at 492 nm with a reference wavelength at 650 nm. Sigmoidal curves were mathematically fitted to a four-parameter logistic equation using the SigmaPlot software package from SPSS Inc. (Chicago, IL). The antiserum titer was defined as the reciprocal of the dilution that results in a 65 maximum absorbance value (A max ) around 1.0 reached at the zero dose of analyte when assayed using the indirect competitive format with the homologous conjugate at 1.0 µg/mL. Antibody affinity was estimated as the concentration of analyte that reduced 50% (IC 50 ) the A max value, and the 70 assay limit of detection was defined as the IC 10 of the inhibition curve.
Conjugate-coated indirect assays. ELISA plates were coated with 100 µL per well of OVA conjugate solution at 1.0 and 0.1 µg/mL in CB by overnight incubation at rt. Serial 75 three-fold antisera dilutions (from 1/1500 to 1/5×10 5 ) were prepared in PBST. Each plate column received a complete standard curve of the analyte in PBS (50 µL per well) followed by a given antiserum dilution (50 µL per well). The same distribution of the reagents was repeated for each plate 80 with a different conjugate. The immunological reaction took place during 1 h at rt, and plates were washed again as described. Next, 100 µL per well of a 1/10000 dilution of goat anti-rabbit IgG peroxidase conjugate in PBST was added, and plates were incubated 1 h at rt. After washing four times, the 85 retained peroxidase activity was determined by addition of 100 µL per well of freshly prepared 2.0 mg/mL of OPD and 0.012% (v/v) H 2 O 2 in 25 mM citrate and 62 mM sodium phosphate buffer, pH 5.4. The enzymatic reaction was stopped after 10 min with 100 µL of 2.5 M H 2 SO 4 .
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Antibody-coated direct assays. Microplates were coated with 100 µL per well of a 1/3000, 1/10000, and 1/30000 dilution of a given antiserum in CB by overnight incubation at rt. After four washes, 50 µL per well of PY standard curve was dispensed to each plate column and immediately 50 µL 95 per well of a different concentration of a given enzyme tracer was added. In this case, serial three-fold dilutions in PBST of the HRP conjugate (from 600 to 2 ng/mL) were prepared. The same array of reagent concentrations was distributed in another plate that had previously been coated with a different 100 antiserum. The immunological reaction was carried out during 1 h at rt and the enzyme activity was revealed as described before.
Limited amounts of the newly described immunoreagents are available upon request for evaluation.
